| abstract |
The present invention relates to a sulfonamide compound of formula (I) wherein the substituents are as described herein, and the invention is associated with inhibition of a potential-gated sodium channel (VGSC), particularly NaV1.7 The use of therapeutic drugs for diseases and disorders. It is further useful in relation to the compounds herein, and pharmaceutically acceptable salts thereof, and in the treatment of diseases, disorders, signs and/or symptoms associated with inhibition of a potential-gated sodium channel (VGSC), particularly NaV1.7. Pharmaceutical composition. The invention is also related to the preparation of the compounds of the invention. |